Elsevier Inc.

SHERPA: Unknown

People

  1. Hassoun
    Hassoun
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Mailankody
    Mailankody
  5. Shah
    Shah
  6. Hultcrantz
    Hultcrantz
  7. Lesokhin
    Lesokhin
  8. Chung
    Chung
  9. Korde
    Korde
  10. Palomba
    Palomba

Groups

  1. Center for Hematologic Malignancies (23)
  2. Department of Medicine (23)
  3. Hematologic Malignancies, Division of (23)
  4. Myeloma (23)
  5. Hematologic Malignancies Research (18)
  6. Bone Marrow Transplant (10)
  7. Survivorship Research (9)
  8. Sloan Kettering Institute Postdocs (7)
  9. CTCR Scholars (4)
  10. GSK Faculty (4)
Search Within
  1. "Myeloma"
  2. "2019"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (2)
  3. Book Section (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (23)
  2. Department of Medicine (23)
  3. Hematologic Malignancies, Division of (23)
  4. Myeloma (23)
  5. Hematologic Malignancies Research (18)
  6. Bone Marrow Transplant (10)

More Groups

People
  1. Carl Landgren (16)
  2. Hani Hassoun (9)
  3. Sergio Giralt (8)
  4. Heather Landau (7)
  5. Gunjan Shah (6)
  6. Sham Mailankody (6)

More People

Years
  1. 2019 (23)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (16)
  2. Biology of Blood and Marrow Transplantation (6)
  3. Clinical Immunology: Principles and Practice. 5th ed (1)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monoclonal gammopathies
    Book Section

    Murata, K.; McCash, S.; Landgren, C. O.
    In Rich, R. R.; Fleisher, T. A.; Shearer, W. T.; Schroeder, H. W. Jr; Frew, A. J.; Weyand, C. M (Eds.) Clinical Immunology: Principles and Practice. 5th ed (2019)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Long term outcomes of high dose therapy and autologous hematopoietic cell transplant for lymphoplasmacytic lymphoma-associated systemic amyloidosis
    Meeting Abstract

    Bal, S.; Shah, G. L.; Hassoun, H.; Palomba, M. L.; Giralt, S. A.; Landau, H.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Peripheral neuropathy and monoclonal gammopathy of undetermined significance: A population-based study including 15,351 cases and 58,619 matched controls
    Meeting Abstract

    Rognvaldsson, S.; Steingrimsson, V.; Turesson, I.; Bjorkholm, M.; Landgren, C. O.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • BCMA expression in AL Amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D.; Dogan, A.; Giralt, S.; Hassoun, H.; Landau, H.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population
    Meeting Abstract

    Richardson, P. G.; Mateos, M. V.; Rodriguez-Otero, P.; Norkin, M.; Larocca, A.; Hassoun, H.; Alegre, A.; Paner, A.; Leleu, X.; Maisel, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Multiple myeloma and comorbidity: A population-based study
    Meeting Abstract

    Sverrisdottir, I.; Rognvaldsson, S.; Turesson, I.; Hultcrantz, M.; Bjorkholm, M.; Landgren, C. O.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save